Literature DB >> 21664081

The unique histology of methamphetamine cardiomyopathy: a case report.

Steven B Karch.   

Abstract

This report describes the histological changes observed in the heart a young methamphetamine abuser who died of heart failure. Most of the microscopic changes in the heart have previously been described in experimental animals, but never clearly illustrated in man. Gross examination of the heart revealed concentric myocardial hypertrophy (heart weight 470 g versus median predicted weight of 312 g). Areas of old myocardial infarction were also evident, along with enzymatic evidence indicating that a new infarct had occurred. Myocardial remodeling was extensive with perivascular and interstitial fibrosis, cellular vacuolization, and ongoing myocyte destruction with proliferation of fibromyocytes in the intestitum. Of note were the widespread, bizarre looking, distorted, cell nuclei. They were reminiscent of those seen in viral-induced dilated congestive cardiomyopathy. Clinical chemical measurements also showed unequivocal evidence of both evolving infarction and profound heart failure, with a BNP > 5000. This pattern has not previously been reported in humans, probably because forensic pathologists rarely examine the hearts of methamphetamine abusers microscopically. If the pattern observed here is typical for methamphetamine-induced cardiotoxicity, it could well explain increasing reports of heart failure in methamphetamine abusers. It might also be diagnostic for the disorder.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21664081     DOI: 10.1016/j.forsciint.2011.04.028

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  7 in total

1.  Tricuspid valve endocarditis complicated by septic pulmonary embolism in an intravenous drug user.

Authors:  Petr Hejna; Martin Janík; Martin Dobiás
Journal:  Forensic Sci Med Pathol       Date:  2014-03       Impact factor: 2.007

2.  Hypertensive heart disease associated with methamphetamine abuse.

Authors:  Takatsugu Segawa; Yoh Arita; Nobuyuki Ogasawara; Shinji Hasegawa
Journal:  J Cardiol Cases       Date:  2018-10-30

3.  Histopathological study of cardiac lesions in methamphetamine poisoning-related deaths.

Authors:  Maryam Akhgari; Homeira Mobaraki; Afshar Etemadi-Aleagha
Journal:  Daru       Date:  2017-02-17       Impact factor: 3.117

4.  Case Report Highlighting Cardiovascular Effects of Concomitant Use of Methamphetamine and Marijuana.

Authors:  Sophia Fontana; Ladan Panahi; George Udeani; Salim Surani; Deepa Desai
Journal:  Cureus       Date:  2022-08-10

Review 5.  Clinical Characteristics and Management of Methamphetamine-Associated Cardiomyopathy: State-of-the-Art Review.

Authors:  Pavan K V Reddy; Tien M H Ng; Esther E Oh; Gassan Moady; Uri Elkayam
Journal:  J Am Heart Assoc       Date:  2020-05-29       Impact factor: 5.501

Review 6.  Methamphetamine-related cardiovascular diseases.

Authors:  Valentin Schwarzbach; Karsten Lenk; Ulrich Laufs
Journal:  ESC Heart Fail       Date:  2020-01-17

7.  Methamphetamine induces cardiomyopathy by Sigmar1 inhibition-dependent impairment of mitochondrial dynamics and function.

Authors:  Chowdhury S Abdullah; Richa Aishwarya; Shafiul Alam; Mahboob Morshed; Naznin Sultana Remex; Sadia Nitu; Gopi K Kolluru; James Traylor; Sumitra Miriyala; Manikandan Panchatcharam; Brandon Hartman; Judy King; Mohammad Alfrad Nobel Bhuiyan; Sunitha Chandran; Matthew D Woolard; Xiuping Yu; Nicholas E Goeders; Paari Dominic; Connie L Arnold; Karen Stokes; Christopher G Kevil; A Wayne Orr; Md Shenuarin Bhuiyan
Journal:  Commun Biol       Date:  2020-11-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.